logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Colin A Leach

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 195(Granted Patents)


Location History:

  • Stevenage, GB (1989 - 1995)
  • Welwyn, GB (1992 - 1995)

Company Filing History:

goldMedal6 out of 6 
 
Smithkline Beckman Intercredit B.v.
 patents
silverMedal5 out of 6 
 
Smithkline Beecham Intercredit B.v.
 patents
bronzeMedal5 out of 362 
 
Smith Kline & French Laboratories Limited
 patents

Years Active: 1989-1995

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5420135 - Substituted quinoline derivatives (1995-05-30),
2. 5409943 - [(alkoxy)pyridinyl]amine compounds which are useful in the treatment of (1995-04-25),
3. 5280026 - Thienopyrimidines (1994-01-18),
4. 5200417 - Substituted 4-amino-isoquinoline compounds, pharmaceutical composition (1993-04-06),
5. 5143920 - Substituted 4-aminoquinoline derivatives as gastric secretion inhibitors (1992-09-01),
6. 5089504 - Substituted 4-aminoquinoline derivatives as gastric acid secretion (1992-02-18),
7. 5089498 - Substituted 4-aminoquinoline derivatives as gastric acid secretion (1992-02-18),
8. 5082848 - Substituted 4-aminoquinoline derivatives as gastric acid secretion (1992-01-21),
9. 5082841 - 3-carbonyl-4-amino-8-substituted quinoline compounds useful in (1992-01-21),
10. 5064833 - Substituted quinazoline derivatives for use in gastrointestinal diseases (1991-11-12),
11. 5051508 - Dihydropyrrolo quinoline derivatives (1991-09-24),
12. 5049567 - Substituted 4-aminoquinazoline derivatives and method of use (1991-09-17),
13. 5006535 - Substituted heterocylic 4-aminoquinoline derivatives as gastric acid (1991-04-09),
14. 4935431 - Substituted 7-amino-thienopyridine derivatives as gastric acid secretion (1990-06-19),
15. 4806550 - 4-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid (1989-02-21),

Title: The Innovations of Colin A. Leach: A Pioneer in Pharmaceutical Chemistry

Introduction: Colin A. Leach, an accomplished inventor based in Stevenage, GB, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 16 patents, he has been instrumental in developing innovative compounds that address critical health issues. His work primarily focuses on inhibitors of bone resorption, showcasing his dedication to advancing medical science.

Latest Patents: Among Colin A. Leach's latest patents are those related to substituted quinoline derivatives. These compounds, particularly the 1-(2-methylphenyl)imidazo[4,5-c]quinoline hydrochloride, have been identified as effective inhibitors of bone resorption. Additionally, his research includes [(alkoxy)pyridinyl]amine compounds, which hold potential for treating various medical conditions.

Career Highlights: Throughout his career, Colin has collaborated with prominent organizations such as SmithKline Beecham and SmithKline Beckman. His work in these institutions has contributed to the development of cutting-edge pharmaceutical technologies. The impact of his innovations is reflected in the growing number of patents that demonstrate his expertise and creativity in the field.

Collaborations: Colin A. Leach has worked alongside notable associates including Robert John Ife and Thomas H. Brown. Their collaborative efforts have further enriched the research landscape and facilitated advancements in the pharmaceutical realm.

Conclusion: Colin A. Leach stands out as a prominent inventor whose contributions have significantly influenced pharmaceutical innovation. With a substantial number of patents to his name, his work continues to pave the way for new treatments and enhance our understanding of critical health challenges. As he forges ahead in his research, the implications of his innovations promise to benefit the medical community and society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…